Patients in the secondary FSGS group who had more IgM deposits on IF reached the composite renal outcome at an earlier time point than patients with lower or negative IgM deposition (Figure 2, P = 0.022). This evidence concerns the gene CD40LG and focal segmental glomerulosclerosis.